Lenti-CD19 CAR (scFv-BBζ, S1)-VP(VP-CAR-LC701)
The ready-to-use lentiviral particles of Lenti-CD19 CAR (scFv-BBζ, S1)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of CAR will be driven by a CMV promotor. The target gene of scFv (S1)-41BB-CD3ζ packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Specifications
Type of Therapeutics
Chimeric Antigen Receptor
Expression Cassette
scFv (S1)-41BB-CD3ζ
Packaging System
Lentivirus
Targeting Diseases
Chronic lymphocytic leukemia
Target
Introduction
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008]
Alternative Names
CD19; CD19 molecule; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T cell surface antigen Leu-12; B-lymphocyte surface antigen B4; Chronic Lymphocytic Leukemia; CLL; scFv; CD28; Leukemia; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; FMC63
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Related Products
| Cat# |
Description |
| CAR-MZ131 |
Anti-CD19 scFv h(CD3ζ-41BB) CAR, pCDCAR1 |
| CAR-LC277 |
Anti-CD19 h(41BB-CD3ζ, FKBP/FRB) Conditional CAR, pCDCAR1 |
| VP-CAR-LC635 |
Lenti-CD19 CAR (scFv-41BB-CD3ζ, 105975) Viral Particle |
| CAR-LC149 |
Anti-CD19 (104882) h(41BB-CD3ζ) CAR, pCDCAR1 |
| VP-CAR-LC63 |
Lenti-CD19 CAR (scFv-CD3ζ, FMC63) Viral Particle |
| CAR-T-3-L332-2BZ |
Anti-CD19 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 |
| CAR-LC016 |
Anti-CD19 (FMC63) h(CD28-CD27-FcεRIγ) CAR, pCDCAR1 |
| CAR-LC353 |
Anti-CD19 (Denintuzumab) h(41BB-CD3ζ, Her2t) Marked CAR, pCDCAR1 |
| VP-CAR-LC69 |
Lenti-CD19 CAR (scFv-41BB-CD3ζ, FMC63) Viral Particle |
| CAR-LC234 |
Anti-CD19 (S2) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 |
Leukemia
Kits for CARs/TCRs Development 
Datasheet
Subscribe to Our Newsletter for Updates: